Supernus Pharmaceuticals stock hits 52-week high at 48.47 USD
PositiveFinancial Markets

Supernus Pharmaceuticals has reached a significant milestone as its stock hits a 52-week high of 48.47 USD. This achievement reflects the company's strong performance and investor confidence, highlighting its potential for growth in the competitive pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System